renal failure ( ESRF ) in ADPKD can be reached as early as childhood or not at all [1] . Part of this Background. Autosomal dominant polycystic kidney disease (ADPKD) shows a variable clinical course that variation can be attributed to genetic heterogeneity is not fully explained by the genetic heterogeneity of [2] . In the majority of cases (85%) the PKD1 gene, this disease. We looked for a possible genetic modifier, located on chromosome 16, is mutated. However, when the ACE I/D polymorphism, and its influence on the disease is caused by a mutation in the PKD2 gene, progression towards end-stage renal failure ( ESRF ).
Families who had members included in our study population
The ACE I/D polymorphism was also shown to have were excluded. prognostic value in various cardiovascular disorders [13, 14] . Enhanced progression in renal disease could also be linked to DD genotype, as shown for IgA ACE I/D genotyping nephropathy and focal segmental glomerulosclerosis [15, 16 ] . Therefore the ACE I/D genotype may also DNA was isolated from peripheral blood leukocytes, using standard techniques [17] . The ACE gene I/D polymorphism explain some of the variation in progression seen in was detected by performing the polymerase chain reaction ADPKD patients.
(PCR) as described by Rigat et al. [18] . The PCR product
We performed a case-control study, comparing the is a 190-bp fragment in the absence of the insertion and a differences in frequencies of the ACE I/D genotype 490 bp fragment in the presence of the insertion. To prevent between PKD1 patients who reached ESRF above the mistyping of ACE heterozygotes we used a specific primer age of 60 years of age and ADPKD patients who for the insertion [19] , whenever a DD genotype was found. reached ESRF under 40 years of age. These groups of In case of an I-allele, a fragment of 408 bp was present, in rapid and slow progressors were also compared them case of a true DD homozygote no such band was present. with a control, general PKD1 population.
In both cases the PCR products were visualized after electrophoresis in 2% agarose gels.
Subjects and methods

Statistical analysis Patients
Chi square tests according to Pearson were performed to compare the frequency of ACE genotype between the groups. After the protocol was approved by the Medical Ethics A P value <0.05 was considered significant. Review Committee of the LUMC, nephrologists of 47 (small ) dialysis centres in our country were asked for their co-operation. We received a positive answer from 37 centres, Results and with their consent we asked RENINE (a central database for patients on dialysis in the Netherlands) to identify patients eligible for this study. Patients with the diagnosis of PKD Clinical characteristics of rapid and slow progressors who became dialysis dependent under 40 years of age and Although more women were present, the gender distripatients who became dialysis dependent above 60 years of bution was not significantly different between the two age were identified to the nephrologist of the participating groups ( Table 1 ). In the rapid progressors hypertension centres. The participating centres were applied with questionwas present in 80% before the age of 40, when all had naires and material necessary for blood sampling. The forms contained questions about age at ESRF, the existence of reached ESRF, whereas in the slow progressors only hypertension before ESRF (defined as diastolic blood pres-21% had hypertension before they reached the sure >95 mmHg and systolic blood pressure >165 mmHg, same age ( Table 1) . This difference was significant or treatment with antihypertensive medication), haematuria, (P<0.001).
urinary-tract infections, kidney stones, cerebrovascular acciFour patients with rapid progression had major dents, pregnancies, nephrectomies, important other complica-complications that might have had a deleterious effect tions before reaching ESRF, and family history. Blood was on the disease progression. Two patients were on noncollected in heparinized tubes and sent to our hospital for steroidal anti-inflammatory drugs, one because of gout DNA isolation and determination of the ACE genotype.
and the other because of Bechterew's disease. Another patient had undergone a nephrectomy at the age of 6 Collected data for unknown reasons. In one patient pyocystis occurred for which the kidney was removed, followed by hypoBlood samples were received from 49 patients who had tensive periods after which dialysis became necessary.
reached ESRF <40 years (rapid progressors), and from 21 patients who had reached ESRF >60 years (slow pro-Exclusion of these patients from our data set had no gressors). We were unable to retrieve data from five patients influence on the results. Other complications were (three rapid progressors and two slow progressors), whereas nephrolithiasis in one patient and an intracranial haem-DNA isolation was impossible in three rapid progressors. In both groups, only two patients were from the same family. group of slow progressors were PKD1 patients. We were able to link all the slow progressors to the PKD1 gene.
To collect a general PKD1 control population, we ran-*Hypertension before reaching ESRF in the <40 group and hyperdomly took samples from our collection of genetically identi-tension before the age of 40 years in the >60 group. Percentages are shown in parentheses.
fied PKD1 families and determined the ACE genotype. ( Table 2 ). This was in Hardy-Weinberg genotype in ADPKD patients who reached ESRF <40 equilibrium and did not differ from the distributions years did not differ from PKDI patients reaching in other populations. No significant differences in the ESRF >60 years and equalled the distribution in the ACE-genotype distribution between the groups of control PKD1 group. This was determined in a group rapid and slow progressors could be established. ACE of rapid progressors four times, respectively twice genotype frequencies were DD 20%, ID 56%, II 24% larger than in the studies mentioned above. No effect in the rapid progressors and DD 29%, ID 52%, II 19% of the ACE genotype on hypertension was found, as in the slow progressors. These distributions were com-previously reported [20, 21] . Therefore, evidence is parable with the general PKD1 population ( Table 2) . lacking for a role of the ACE polymorphism on An effect of the ACE genotype on hypertension was progression in autosomal dominant polycystic kidney not found (data not shown).
disease. In our study the majority of rapid progressors was hypertensive before reaching renal failure. This was
Discussion
significantly different compared to the slow progressors, in whom only 21% were identified as hyperWe found no influence of the ACE polymorphism on tensive before the age of 40 years. Unfortunately, the the progression towards ESRF in ADPKD patients. age at onset of hypertension and the cause of hypertenThis is in agreement with a recently published study sion could not be verified. Therefore, it remains unclear of a large American ADPKD population ( Fick et al., whether early onset hypertension (arbitrarily defined abstract ASN 1998), but contradict the first study as hypertension <40 years) hastened progression in published on this subject [20] . Baboolal et al.
[20] the rapid progressors, or whether hypertension was found a difference of 7 years in renal survival between due to deteriorating renal function. Therefore, early the DD and the II genotype. Patients with the DD onset hypertension could be simply a consequence of genotype had a relative risk of 17 for reaching ESRF a more severe disease. Nevertheless, various studies under 40 years of age. However, these outcomes were have reported a negative effect of hypertension on based on a small group of patients who reached renal progression of ADPKD [6, [23] [24] [25] . In ADPKD failure <40 years [20] . Recently, a negative effect of patients hypertension frequently occurs before the the DD genotype of the ACE polymorphism on pro-decline of renal function and can start as early as gression towards ESRF was also reported by Perez-childhood [26, 27] . Based on this study it may be Oller et al. [21] . In this study, 48 ADPKD patients suggested that the early onset hypertension could have reached ESRF at a mean age of 48±7 years. Only contributed to the enhanced progression towards when the authors compared the patients who reached ESRF in the group of early progressors. However, ESRF <50 years (n=25) with the total study popula-studies have provided no clear evidence for a beneficial tion of 151 patients, the DD genotype was significantly effect of antihypertensive treatment on the decline of more frequently present in the group of patients who renal function in ADPKD patients [28, 29] reached ESRF <50 years. However, the total group Although the rate of microalbuminuria was linked of patients who reached ESRF had an abnormal to the ACE genotype [30] , there is no indication that distribution of the ACE genotype (with only 26% the ACE genotype influences progression in this disheterozygotes), and the cut-off point for rapid progres-ease. Other genetic polymorphisms of the renin-angiotsion was 50 years, which is 2 years higher than the ensin system, such as the M235T angiotensinogen polymorphism and the A1166C angiotensin II type I 
